These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 18214821)

  • 1. [Metabolic syndrome in Alzheimer's disease: clinical and developmental influences].
    Vilalta-Franch J; López-Pousa S; Garre-Olmo J; Turón-Estrada A; Pericot-Nierga I
    Rev Neurol; 2008 Jan 1-15; 46(1):13-7. PubMed ID: 18214821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mortality rates in patients with Alzheimer's disease treated with atypical neuroleptic drugs].
    Vilalta-Franch J; Lopez-Pousa S; Garre-Olmo J; Turon-Estrada A; Pericot-Nierga I
    Rev Neurol; 2008 Feb 1-15; 46(3):129-34. PubMed ID: 18297617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
    Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
    J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
    Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC
    Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rapid Disability Rating Scale-2 in Alzheimer's disease: NORMACODEM project data].
    Monllau A; Aguilar M; Peña-Casanova J; Böhm P; Blesa R; Sol JM; Hernández G;
    Neurologia; 2006; 21(6):282-8. PubMed ID: 16799902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    Wattmo C; Minthon L; Wallin ÅK
    Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients.
    Orsitto G; Cascavilla L; Franceschi M; Aloia RM; Greco A; Paris F; Seripa D; Pilotto A
    J Nutr Health Aging; 2005; 9(3):194-8. PubMed ID: 15864400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.
    D'Onofrio G; Panza F; Sancarlo D; Paris FF; Cascavilla L; Mangiacotti A; Lauriola M; Paroni GH; Seripa D; Greco A
    J Alzheimers Dis; 2016; 51(2):427-37. PubMed ID: 26890768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.
    Lopez OL; Becker JT; Saxton J; Sweet RA; Klunk W; DeKosky ST
    J Am Geriatr Soc; 2005 Jan; 53(1):83-7. PubMed ID: 15667381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.
    Modrego PJ; Ferrández J
    Arch Neurol; 2004 Aug; 61(8):1290-3. PubMed ID: 15313849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.
    López-Pousa S; Olmo JG; Franch JV; Estrada AT; Cors OS; Nierga IP; Gelada-Batlle E
    Age Ageing; 2006 Jul; 35(4):365-71. PubMed ID: 16788079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of progression of Alzheimer's disease in younger versus older patients: a longitudinal single photon emission computed tomography study.
    Sakai M; Hanyu H; Kume K; Sato T; Hirao K; Kanetaka H; Abe S; Kanaya K; Sakurai H; Iwamoto T
    Geriatr Gerontol Int; 2013 Jul; 13(3):555-62. PubMed ID: 22963387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with undertreatment of atrial fibrillation in geriatric outpatients with Alzheimer disease.
    Tavassoli N; Perrin A; Bérard E; Gillette S; Vellas B; Rolland Y;
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):425-33. PubMed ID: 23943094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS).
    Matsuzono K; Yamashita T; Ohta Y; Hishikawa N; Sato K; Kono S; Deguchi K; Nakano Y; Abe K
    J Alzheimers Dis; 2015; 46(3):687-93. PubMed ID: 26402513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with Concomitant Cerebral Infarction.
    Sheng B; Cheng LF; Law CB; Li HL; Yeung KM; Lau KK
    J Am Geriatr Soc; 2007 Jun; 55(6):918-22. PubMed ID: 17537094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study.
    Fox C; Livingston G; Maidment ID; Coulton S; Smithard DG; Boustani M; Katona C
    Age Ageing; 2011 Nov; 40(6):730-5. PubMed ID: 21926432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.
    Riccio D; Solinas A; Astara G; Mantovani G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():343-53. PubMed ID: 17317473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.